Kerim Babaoglu

This inventor holds 17 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 11 EPO patents. Top assignees: Gilead Sciences, Inc., Merck Sharp + Dohme Corp., Modernatx, Inc.. Active years: 2013-2023.

USPTO Granted Patents = 17 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 21)

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 88(Granted Patents)

Location History:

Landsdale, PA (US) (2015)
Pacifica, CA (US) (2013 - 2016)
Lansdale, PA (US) (2015 - 2023)

Company Filing History:

14 out of 946

Gilead Sciences, Inc.

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2013-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11576961 - Broad spectrum influenza virus vaccine (2023-02-14),

2. 9957275 - Pyrazolo[1,5-A]pyrimidines for antiviral treatment (2018-05-01),

3. 9951079 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors (2018-04-24),

4. 9879023 - Therapeutic compounds (2018-01-30),

5. 9815846 - TrkA kinase inhibitors, compositions and methods thereof (2017-11-14),

6. 9464096 - Therapeutic compounds (2016-10-11),

7. 9376392 - 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS (2016-06-28),

8. 9296758 - 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds (2016-03-29),

9. 9284323 - Naphthalene acetic acid derivatives against HIV infection (2016-03-15),

10. 9238039 - Pyrazolo[1,5-A]pyrimidines for antiviral treatment (2016-01-19),

11. 9108953 - Quinoline derivatives as bromodomain inhibitors (2015-08-18),

12. 9102614 - Naphth-2-ylacetic acid derivatives to treat AIDS (2015-08-11),

13. 9096586 - Therapeutic compounds (2015-08-04),

14. 9006229 - Benzothiazole compounds and their pharmaceutical use (2015-04-14),

15. 8987250 - Therapeutic compounds (2015-03-24),

Title: Kerim Babaoglu: Innovator in Antiviral Vaccines

Introduction

Kerim Babaoglu is a prominent inventor based in Lansdale, PA (US), known for his significant contributions to the field of antiviral treatments and vaccines. With a total of 17 patents to his name, Babaoglu has made remarkable strides in developing innovative solutions to combat viral infections.

Latest Patents

Among his latest patents is a broad spectrum influenza virus vaccine. This invention relates to ribonucleic acid (RNA) vaccines that target a wide range of influenza viruses. The vaccine is formulated as a lipid nanoparticle that includes at least one cationic lipid, enhancing its effectiveness. Another notable patent is for pyrazolo[1,5-A]pyrimidines for antiviral treatment. This invention provides compounds that are useful for treating infections caused by Pneumovirinae viruses, particularly Human respiratory syncytial virus infections.

Career Highlights

Throughout his career, Kerim Babaoglu has worked with leading pharmaceutical companies, including Gilead Sciences, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of antiviral therapies.

Collaborations

Babaoglu has collaborated with esteemed colleagues, including Michael L Mitchell and Lianhong Xu. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of medical science.

Conclusion

Kerim Babaoglu's work in developing antiviral vaccines and treatments showcases his dedication to improving public health. His innovative patents and collaborations highlight his significant impact on the field of medicine.